DQIP study

Data-driven Quality Improvement in Primary Care (DQIP)

The research program, funded by the Chief Scientist Office (The Scottish Government), developed and evaluated an intervention to improve drug therapy safety in outpatient care. In a first step, indicators for the identification of "high-risk prescriptions" were developed in a consensus process, which were then implemented in a web-based IT tool.

The tool enables GP practices to identify patients with high-risk prescriptions for antithrombotics (e.g. ASA, phenprocoumon) and/or non-steroidal anti-inflammatory drugs (NSAIDs, such as ibuprofen or diclofenac) who are at increased risk of adverse drug reactions (gastrointestinal bleeding, acute renal failure, heart failure). In addition, the DQIP intervention included an educational outreach visit (EOV), i.e. a one-hour educational session conducted by a pharmacist in GP practices, and financial incentives for GPs (€20 per medication analysis conducted by the GP of a patient with a high-risk prescription identified by the IT-tool). The intervention was evaluated in a cluster randomized trial in 34 GP practices and the results were published in the New England Journal of Medicine in 2016.